Stocks Overview

LAST PRICE
2.3100
TODAY'S CHANGE (%)
Trending Down-0.0800 (-3.3473%)

Bid / Lots
2.2900/ 8
Ask / Lots
2.4600/ 99
Open / Previous Close
2.4200 / 2.3900
Day Range
Low 2.2550
High 2.4200
52 Week Range
Low 1.8650
High 40.5800
Volume
4,560,759
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 2.39
Time	Volume	VTYX
09:32 ET	11728	2.355
09:34 ET	1000	2.3595
09:36 ET	100	2.37
09:38 ET	170	2.3599
09:43 ET	1000	2.335
09:45 ET	506	2.3208
09:48 ET	3161	2.31
09:50 ET	13656	2.3001
09:52 ET	1583	2.3008
09:54 ET	4300	2.295
09:56 ET	1516	2.32
09:57 ET	100	2.32
09:59 ET	100	2.32
10:01 ET	300	2.32
10:03 ET	450	2.3179
10:06 ET	600	2.32
10:08 ET	89088	2.31
10:10 ET	1986	2.32
10:14 ET	100	2.32
10:15 ET	600	2.32
10:17 ET	800	2.32
10:19 ET	2829	2.3292
10:21 ET	1216	2.34
10:24 ET	2648	2.35
10:30 ET	300	2.345
10:33 ET	1070	2.345
10:35 ET	3157	2.34
10:37 ET	564	2.34
10:39 ET	1700	2.335
10:42 ET	1187	2.321
10:44 ET	200	2.3299
10:46 ET	4878	2.35
10:48 ET	10000	2.34
10:51 ET	2265	2.33
10:55 ET	13550	2.305
10:57 ET	1400	2.3
11:02 ET	180	2.3
11:04 ET	2565	2.285
11:06 ET	850	2.285
11:08 ET	500	2.2892
11:09 ET	100	2.2892
11:11 ET	933	2.2885
11:13 ET	200	2.285
11:15 ET	3606	2.295
11:20 ET	400	2.29
11:24 ET	234	2.29
11:27 ET	174	2.295
11:29 ET	162	2.2992
11:31 ET	100	2.295
11:33 ET	500	2.298
11:36 ET	9547	2.285
11:38 ET	4206	2.29
11:40 ET	506	2.29
11:42 ET	7847	2.31
11:44 ET	400	2.31
11:45 ET	400	2.3108
11:47 ET	100	2.3199
11:49 ET	4086	2.305
11:51 ET	5600	2.305
11:54 ET	1500	2.31
11:56 ET	100	2.3108
11:58 ET	951	2.33
12:00 ET	1084	2.33
12:02 ET	1375	2.335
12:03 ET	1715	2.33
12:05 ET	200	2.335
12:07 ET	1000	2.33
12:12 ET	650	2.3201
12:14 ET	100	2.3201
12:16 ET	200	2.33
12:18 ET	100	2.325
12:20 ET	200	2.325
12:21 ET	1345	2.33
12:23 ET	100	2.33
12:25 ET	920	2.33
12:27 ET	8626	2.34
12:30 ET	200	2.34
12:32 ET	1898	2.34
12:34 ET	2621	2.34
12:36 ET	300	2.335
12:38 ET	400	2.34
12:39 ET	400	2.335
12:41 ET	677	2.33
12:48 ET	1100	2.335
12:50 ET	16816	2.32
12:52 ET	1140	2.32
12:54 ET	100	2.32
12:56 ET	6300	2.325
12:57 ET	450	2.325
12:59 ET	1000	2.33
01:01 ET	2285	2.325
01:03 ET	3094	2.325
01:06 ET	200	2.33
01:08 ET	1055	2.335
01:10 ET	400	2.339
01:12 ET	300	2.34
01:14 ET	1000	2.3313
01:15 ET	631	2.34
01:17 ET	131	2.34
01:19 ET	205	2.34
01:21 ET	100	2.34
01:24 ET	2888	2.35
01:26 ET	1200	2.35
01:28 ET	257	2.34
01:30 ET	100	2.345
01:32 ET	1000	2.35
01:33 ET	5262	2.34
01:35 ET	1477	2.33
01:37 ET	308	2.32
01:39 ET	13454	2.31
01:48 ET	500	2.3001
01:50 ET	200	2.31
01:53 ET	100	2.31
01:57 ET	100	2.31
02:00 ET	200	2.31
02:02 ET	1204	2.3015
02:04 ET	500	2.3001
02:09 ET	2149	2.31
02:11 ET	100	2.3001
02:13 ET	700	2.31
02:15 ET	339	2.315
02:18 ET	300	2.315
02:20 ET	317	2.32
02:22 ET	100	2.32
02:26 ET	200	2.315
02:27 ET	200	2.315
02:29 ET	1510	2.315
02:33 ET	6215	2.3
02:38 ET	100	2.3
02:40 ET	100	2.31
02:42 ET	1034	2.3
02:45 ET	1500	2.305
02:47 ET	1238	2.305
02:49 ET	1003	2.305
02:51 ET	101	2.302
02:54 ET	1000	2.305
02:56 ET	300	2.305
02:58 ET	800	2.305
03:00 ET	568	2.305
03:02 ET	9610	2.285
03:03 ET	6494	2.276
03:07 ET	100	2.27
03:09 ET	4284	2.27
03:12 ET	2900	2.27
03:14 ET	5111	2.265
03:16 ET	3339	2.2692
03:18 ET	7577	2.26
03:20 ET	1925	2.26
03:21 ET	1688	2.265
03:23 ET	100	2.265
03:25 ET	300	2.27
03:27 ET	500	2.27
03:30 ET	100	2.26
03:32 ET	1800	2.265
03:34 ET	1865	2.265
03:36 ET	8867	2.29
03:38 ET	4600	2.2863
03:39 ET	4037	2.285
03:41 ET	5282	2.275
03:43 ET	6102	2.265
03:45 ET	9749	2.275
03:48 ET	4113	2.27
03:50 ET	5487	2.275
03:52 ET	220486	2.3
03:54 ET	35469	2.305
03:56 ET	25777	2.305
03:57 ET	56062	2.305
03:59 ET	2276275	2.31

Data delayed at least 15 minutes.

Jun 26, 2024
- ONGOING INVESTIGATION NOTICE: Scott+Scott Attorneys at Law LLP Investigates Ventyx Biosciences, Inc.'s Directors and Officers for Breach of Fiduciary Duties - VTYX, from 4:01PM ET on Wednesday Jun 26, 2024 by Dow Jones
  4:01PM ET on Wednesday Jun 26, 2024 by Dow Jones
- VENTYX SHAREHOLDER NOTICE: Ventyx's (VTYX) Board is Being Investigated for Insider Trading Allegations, Long-Term Investors Are Notified to Contact the Firm for Details, from 6:08AM ET on Wednesday Jun 26, 2024 by Dow Jones
  6:08AM ET on Wednesday Jun 26, 2024 by Dow Jones
Jun 25, 2024
- Lifshitz Law PLLC Announces Investigations of Rivian Automotive, Inc. (NASDAQ: RIVN), Nextdoor Holdings, Inc. (NYSE: KIND), Ventyx Biosciences, Inc. (NASDAQ: VTYX), and agilon health, inc. (NYSE: AGL), from 11:07PM ET on Tuesday Jun 25, 2024 by Dow Jones
  11:07PM ET on Tuesday Jun 25, 2024 by Dow Jones
- VENTYX SHAREHOLDER ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Notified to Contact the Firm for Details, from 1:43PM ET on Tuesday Jun 25, 2024 by Dow Jones
  1:43PM ET on Tuesday Jun 25, 2024 by Dow Jones
- VENTYX STOCK ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Encouraged to Contact the Firm for Details, from 5:28AM ET on Tuesday Jun 25, 2024 by Dow Jones
  5:28AM ET on Tuesday Jun 25, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesVTYX Ventyx Biosciences Inc	162.9M	-0.7x	---
United StatesFBLG Fibrobiologics Inc	163.3M	-4.8x	---
United StatesBMEA Biomea Fusion Inc	161.8M	-1.3x	---
United StatesACHV Achieve Life Sciences Inc	161.4M	-3.7x	---
United StatesXBIT XBiotech Inc	156.6M	-5.1x	---
United StatesOTLK Outlook Therapeutics Inc	172.7M	-0.6x	---
As of 2024-06-29

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.

Contact Information

Headquarters: 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
Phone: 858-945-2393
Fax: 302-655-5049

Executives

Executive Chairperson of the Board: Sheila Gujrathi
President, Chief Executive Officer, Founder, Director: Raju Mohan
Chief Financial Officer: Martin Auster
Chief Operating Officer: Matthew Moore
Chief Scientific Officer: John Nuss

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$162.9M
Revenue (TTM)	$0.00
Shares Outstanding	70.5M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	---
EPS	$-3.24
Book Value	$4.12
P/E Ratio	-0.7x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Ventyx Biosciences Inc
NASDAQ:VTYXUnited States

Search Criteria

Charts

Recent News

Jun 26, 2024

ONGOING INVESTIGATION NOTICE: Scott+Scott Attorneys at Law LLP Investigates Ventyx Biosciences, Inc.'s Directors and Officers for Breach of Fiduciary Duties - VTYX, from 4:01PM ET on Wednesday Jun 26, 2024 by Dow Jones

VENTYX SHAREHOLDER NOTICE: Ventyx's (VTYX) Board is Being Investigated for Insider Trading Allegations, Long-Term Investors Are Notified to Contact the Firm for Details, from 6:08AM ET on Wednesday Jun 26, 2024 by Dow Jones

Jun 25, 2024

Lifshitz Law PLLC Announces Investigations of Rivian Automotive, Inc. (NASDAQ: RIVN), Nextdoor Holdings, Inc. (NYSE: KIND), Ventyx Biosciences, Inc. (NASDAQ: VTYX), and agilon health, inc. (NYSE: AGL), from 11:07PM ET on Tuesday Jun 25, 2024 by Dow Jones

VENTYX SHAREHOLDER ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Notified to Contact the Firm for Details, from 1:43PM ET on Tuesday Jun 25, 2024 by Dow Jones

VENTYX STOCK ALERT: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Encouraged to Contact the Firm for Details, from 5:28AM ET on Tuesday Jun 25, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar